Publikationen

1.   Babic, M.; Schuchardt M.; Tölle, M.; van der Giet, M: In times of tobacco-free nicotine consumption: The influence of nicotine on vascular calcification, Eur J Clin Invest., 2019.

2.  Reshetnik, A.; Gohlisch, C.; Abou-Dakn, M.; Tölle, M.; Zidek, W.; van der Giet, M.: Validation of noninvasive oscillometric blood pressure 2020 up pressure upper arm blood pressure monitoring technology according to the European Society of Hypertension International Protocol revision 2010, Blood Press Monit., 2019.

3.   Douros, A.; Tölle, M.; Ebert, N.; Gaedeke, J.; Huscher, D.; Kreutz, R.; Kuhlmann, M.K.; Martus, P.; Mielke, N.; Schneider, A.; Schuchardt, M.; van der Giet, M.; Schaeffner, E.: Control of blood pressure and risk of mortality in a cohort of older adults: the Berlin Initiative Study, Eur Heart J., 2019.

4.   Schuchardt, M.; Prüfer, N.; Tu, Y.; Herrmann, J.; Hu, X.P.; Chebli, S.; Dahlke, K.; Zidek, W.; van der Giet, M.; Tölle, M.: Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid A in vascular smooth muscle cells, Sci Rep., 2019.

5.  Schaafs, L.A.; Tzschätzsch, H.; Figiel, C.; van der Giet, M.; Reshetnik, A.; Hamm, B.; Sack, I.; Elgeti, T.: Quantitative Time-Harmonic Ultrasound Elastography of the Abdominal Aorta and Inferior Vena Cava. Ultrasound Med Biol., 2019.

6.  Schaafs, L.A.; Tzschätzsch, H.; Reshetnik, A.; van der Giet, M.; Braun, J.; Hamm, B.; Sack, I.; Elgeti, T.: Ultrasound Time-Harmonic Elastography of the Aorta: Effect of Age and Hypertension on Aortic Stiffness, Invest Radiol. 2019

1.    Golic M.; Stojanovska, V.; Bendix, I.; Wehner, A.; Herse, F.; Haase, N.; Kräker, K.; Fischer, C.; Alenina, N.; Bader, M.; Schütte, T.; Schuchardt, M.; van der Giet, M.; Henrich, W.; Muller, D.N.; Felderhoff-Müser, U.; Scherjon, S.; Plösch, T.; Dechend, R,: Diabetes Mellitus in Pregnancy Leads to Growth Restriction and Epigenetic Modification of the Srebf2 Gene in Rat Fetuses, Hypertension, 2018.

2.   Reshetnik, A.; van der Giet, M.: Response to discussion about blood pressure monitor validation studies, Blood Press Monit., 2018.

3.  Yu, S.; Kent, B.; Jafta, C. J.; Petzold, A.; Radulescu, A.; Schuchardt, M.; Tölle, M.; van der Giet, M.; Zidek, W.; Ballauff, M.: Stability of human serum albumin structure upon toxin uptake explored by small angle neutron scattering, Polymer, 2018.

4.  Reshetnik, A.; Gohlisch, C.; De Bucourt, M.; Zidek, W.; Tölle, M.; van der Giet, M.: Predictors for success in renal denervation-a single centre retrospective analysis, Sci Rep., 2018.

5.   Taubert, M.; Ebert, N.; Martus, P.; van der Giet, M.; Fuhr, U.; Schaeffner, E: Using a three-compartment model improves the estimation of iohexol clearance to assess glomerular filtration rate, Sci Rep., 2018.

6.   Pascual, J.; Berger, S.P.; Witzke, O.; Tedesco, H.; Mulgaonkar, S.; Qazi, Y.; Chadban, S.; Oppenheimer, F.; Sommerer, C.; Oberbauer, R.; Watarai, Y.; Legendre, C.; Citterio, F.; Henry, M.; Srinivas, T.R.; Luo, W.L.; Marti, A.; Bernhardt, P.; Vincenti, F.; TRANSFORM Investigators: Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation, J Am Soc Nephrol., 2018.

1.   Anderson, J.; Gautier, T.; Nijstad, N.; Tölle, M.; Schuchardt, M.; van der Giet, M.; Tietge, U.: High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport, Sci Rep, 2017.

2.   Reshetnik, A.; Gohlisch, C.; Tölle, M.; Zidek, W.; Van Der Giet, M.: Oscillometric assessment of arterial stiffness in everyday clinical practice, Hypertens Res, 2016.

3.    Holdaas, H.; de Fijter, J.W.; Cruzado, J.M.; Massari, P.; Nashan, B.; Kanellis. J.; Witzke, O.; Gutierrez-Dalmau, A.; Turkmen, A.; Wang, Z.; Lopez, P.; Bernhardt, P.; Kochuparampil, J.; van der Giet, M.; Murbraech, K.; ELEVATE Study Group: Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study, Transplantation, 2017.

4.   Michalick, L.; Erfinanda, L.; Weichelt, U.; van der Giet, M.; Liedtke, W.; Kuebler, W.M.: Transient Receptor Potential Vanilloid 4 and Serum Glucocorticoid-regulated Kinase 1 Are Critical Mediators of Lung Injury in Overventilated Mice In Vivo, Anesthesiology, 2017.

5.   Schuchardt, M.; Herrmann, J.; Tölle, M.; van der Giet, M.: Xanthine oxidase and its role as target in cardiovascular disease: cardiovascular protection by enzyme inhibition?, Curr Pharm Des., 2017.

6.   Alicke, M.; Boakye-Appiah, J.K.; Abdul-Jalil, I.; Henze, A.; van der Giet, M.; Schulze, M.B.; Schweigert, F.J.; Mockenhaupt, F.; Bedu-Addo, G.; Danquah, I.: Adolescent health in rural Ghana: A cross-sectional study on the co-occurrence of infectious diseases, malnutrition and cardio-metabolic risk factors, PLoS One, 2017.

7.   Schaafs, L.A.; Tzschätzsch, H.; van der Giet, M.; Reshetnik, A.; Steffen, I.G.; Hamm, B.; Braun, J.; Sack, I.; Elgeti, T.: Time-Harmonic Ultrasound elastography of the Descending Abdominal Aorta: Initial Results, Ultrasound Med Biol., 2017.

8.   Ebert, N.; Jakob, O.; Gaedeke, J.; van der Giet, M.; Kuhlmann, M.K.; Martus, P.; Mielke, N.; Schuchardt, M.; Tölle, M.; Wenning, V.; Schaeffner, E.S.: Prevalence of reduced kidney function and albuminuria in older adults: the Berlin Initiative Study, Nephrol Dial Transplant., 2017.

9.   Ebert, N.; Koep, C.; Schwarz, K.; Martus, P.; Mielke, N.; Bartel, J.; Kuhlmann, M.; Gaedeke, J.; Toelle, M.; van der Giet, M.; Schuchardt, M.; Schaeffner, E.: Beta Trace Protein does not outperform Creatinine and Cystatin C in estimating Glomerular Filtration Rate in Older Adults, Sci Rep., 2017.

10.  Koziolek, M.; Beige, J.; Wallbach, M.; Zenker, D.; Henning, G.; Halbach, M.; Mader, N.; Mahfoud, F.; Schlieper, G.; Schwenger, V.; Hausberg, M.; Börgel, J.; Lodde, M.; van der Giet, M.; Müller-Ehmsen, J.; Passauer, J.; Parmentier. S.; Lüders, S.; Krämer, B.K.; Büttner, S.; Limbourg, F.; Jordan, J.; Vonend, O.; Predel, H.G.; Reuter, H.: Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017[Article in German], Internist, 2017.

11.    Bedu-Addo, G.; Alicke, M.; Boakye-Appiah, J.K.; Abdul-Jalil, I.; van der Giet, M.; Schulze, M.B.; Mockenhaupt, F.P.; Danquah, I.: In utero exposure to malaria is associated with metabolic traits in adolescence: The Agogo 2000 birth cohort study, J Infect., 2017.

12.   Lobo, M.D.; Ott, C.; Sobotka, P.A.; Saxena, M.; Stanton, A.; Cockcroft, J.R.; Sulke, N.; Dolan, E.; van der Giet, M.; Hoyer, J.; Furniss, S.S.; Foran, J.P.; Witkowski, A.; Januszewicz, A.; Schoors, D.; Tsioufis, K.; Rensing, B.J.; Scott, B.; Ng, G.A.; Schmieder, R.E.: Central Iliac Arteriovenous Anastomosis for Uncontrolled Hypertension: One-Year Results From the ROX CONTROL HTN Trial, Hypertension, 2017.

13.   Kakkassery, V.; Skosyrski, S.; Lüth, A.;, Kleuser, B.; van der Giet, M.; Tate, R.; Reinhard, J.; Faissner, A.; Joachim, S.C.; Kociok, N.: Etoposide Upregulates Survival Favoring Sphingosine-1-Phosphate in Etoposide-Resistant Retinoblastoma Cells, Pathol Oncol Res., 2017.

14.   Reshetnik, A.; Compton, F.; Schölzel, A.; Tölle, M.; Zidek, W.; Giet, M.V.: Noninvasive oscillometric cardiac output determination in the intensive care unit - comparison with invasive transpulmonary thermodilution, Sci Rep., 2017.

15.  Yu, S.; Schuchardt, M.; Tölle, M.; van der Giet, M.; Zidek, W.; Dzubiella, J.; Ballauff, M.: Interaction of human serum albumin with uremic toxins: a thermodynamic study, RSC Advances, 2017.

1.    Ebert, N.; Delanaye, P.; Shlipak, M.; Jakob, O.; Martus, P.; Bartel, J, Gaedeke, J.; van der Giet, M.; Schuchardt, M.; Cavalier, E.; Schaeffner, E.: Cystatin C standardization decreases assay variation and improves assessment of glomerular filtration rate, Clin Chim Acta, 2016.

2.    Assfalg, V.; Hüser, N.; van Meel, M.; Haller, B.; Rahmel, A.; de Boer, J.; Matevossian, E.; Novotny, A.; Knops, N.; Weekers, L.; Friess, H.; Pratschke, J.; Függer, R.; Janko, O.; Rasoul-Rockenschaub, S.; Bosmans, J.L.; Broeders, N.; Peeters, P.; Mourad, M.; Kuypers, D.; Slaviček, J.; Muehlfeld, A.; Sommer, F.; Viebahn, R., Pascher, A.; van der Giet, M.; Zantvoort, F., Woitas, R.P.; Putz, J.; Grabitz, K.; Kribben, A.; Hauser, I.; Pisarski, P.; Weimer, R.; Lorf, T.; Fornara, P.; Morath, C., Nashan, B.; Lehner, F.; Kliem, V.; Sester, U.; Grimm, M.O.; Feldkamp, T.; Kleinert, R., Arns, W.; Mönch, C.; Schoenberg, M.B.; Nitschke, M.; Krüger, B.; Thorban, S.; Arbogast, H.P.; Wolters, H.H.; Maier, T.; Lutz, J.; Heller, K.; Banas, B.; Hakenberg, O.; Kalus, M.; Nadalin, S.; Keller, F.; Lopau, K.; Bemelman, F.J.; Nurmohamed, S.; Sanders, J.S.; de Fijter, J.W.; Christiaans, M.; Hilbrands, L.; Betjes, M.; van Zuilen, A.; Heemann, U.: High-urgency kidney transplantation in the Eurotransplant Kidney Allocation System: success or waste of organs? The Eurotransplant 15-year all-centre survey, Nephrol Dial Transplant., 2016.

3.    Ebert, N.; Jakob, O.; Gaedeke, J,; van der Giet, M,; Kuhlmann, M.K.; Martus, P.; Mielke, N.; Schuchardt, M.; Tölle, M.; Wenning, V.; Schaeffner, E.S.: Prevalence of reduced kidney function and albuminuria in older adults: the Berlin Initiative Study, Nephrol Dial Transplant., 2016.

4.   Reshetnik, A.; Gohlisch, C.; Zidek, W.; Tölle, M.; van der Giet, M.: Central blood pressure assessment using oscillometry is feasible for everyday clinical practice, J Hum Hypertens.; 2016.

5.   Reshetnik, A.; Gohlisc,h C.; Zidek, W.; Tölle, M.; van der Gie,t M.: Validation of the Tel-O-GRAPH, a new oscillometric blood pressure-measuring device, according to the British Hypertension Society protocol, Blood Press Monit., 2016.

6.   Tölle, M.; Klöckl, L.; Wiedon, A,; Zidek, W.; van der Giet, M.; Schuchardt, M: Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3, Biochem Biophys Res Commun., 2016.

7.    Annema W.; Willemsen, H.M.; de Boer, J.F.; Dikkers, A.; van der Giet, M.; Nieuwland, W.; Muller Kobold, A.C.; van Pelt, L.J.; Slart, R.H.; van der Horst, I.C.; Dullaart, R.P.; Tio, R.A.; Tietge, U.J.: HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels, J Clin Lipidol, 2016.

8.   Michalick, L.; Erfinanda, L.; Weichelt, U.; van der Giet, M.; Liedtke, W.; Kuebler, W.M.: Transient Receptor Potential Vanilloid 4 and Serum Glucocorticoid-regulated Kinase 1 Are Critical Mediators of Lung Injury in Overventilated Mice In Vivo, Anesthesiology, 2016.

9.  de Fijter, J.W.; Holdaas, H.; Øyen, O.; Sanders, J.S.; Sundar, S.; Bemelman, F.J.; Sommerer, C.; Pascual, J.; Avihingsanon, Y.; Pongskul, C.; Oppenheimer, F.; Toselli, L.; Russ, G.; Wang, Z.; Lopez, P.; Kochuparampil, J.; Cruzado, J.M.; van der Giet, M.; ELEVATE Study Group: Early conversion from calcineurin inhibitor- to everolimus-based therapy following kidney transplantation: Results of the randomized ELEVATE trial, Am J Transplant, 2016.

10.  Ott, C.; Lobo, M.D.; Sobotka, P.A.; Mahfoud, F.; Stanton, A.; Cockcroft, J.; Sulke, N.; Dolan, E.; van der Giet, M.; Hoyer, J.; Furniss, S.S.; Foran, J.P.; Witkowski, A.; Januszewicz, A.; Schoors, D.; Tsioufis, K.; Rensing, B.J.; Saxena, M.; Scott, B.; Ng, G.A.; Achenbach, S.; Schmieder, R.E.: Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension, J Am Heart Assoc, 2016.

1.     Prüfer, N.; Kleuser, B.; van der Giet, M.: The role of serum amyloid A and sphingosine-1-phosphate on HDL functionality, Biol. Chem., 2015.

2.    Schuchardt, M., Tölle, M.; van der Giet, M.: High-Density Lipoprotein: Structural and Functional Changes under Uremic Conditions and the Therapeutic Consequences, Handbook of Experimental Pharmacology, 2015. 

3.     Lobo, M.; Sobotka, P.; Stanton, A.; Cockcroft, J.; Sulke, N.; Dolan, E.; van der Giet, M.; Hoyer, J.; Furniss , S.; Foran, J.; Witkowski, A.; Januszewicz, A.; Schoors, D.; Tsioufis, K.; Rensing, B.; Scott, B.; Ng, A.; Ott, C.;  Schmieder, R.: Central arteriovenous anastomosis for patients with uncontrolled hypertension (the ROX CONTROL HTN Study): a randomised controlled trial, Lancet.

4.    Van der Giet, M.; Henkel, C.; Schuchardt, M.; Tölle, M.: Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects, Curr Pharm Des., 2015.

5.     Yu ,S.; Xu, X.; Yigit, C.; van der Giet, M.; Zidek, W.; Jankowski, J.; Dzubiella, J.; Ballauff, M.: Interaction of human serum albumin with short polyelectrolytes: a study by calorimetry and computer simulations, Soft Matter, 2015.

6.     van der Giet, M.; Tölle, M.: New Hypertension Guidelines: Progression or a Step Backwards in Hypertension?, Curr Hypertens Rep., 2015.

7.      Tölle, M.; Reshetnik, A.; Schuchardt, M.; Höhne, M.; van der Giet, M: Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy, Eur J Clin Invest., 2015.

8.      Ebert, N.; Loesment, A.; Martus, P.; Jakob, O.; Gaedeke, J.; Kuhlmann, M.; Bartel, J.; Schuchardt, M.; Tölle, M.; Huang, T.; van der Giet, M.; Schaeffner, E.: Iohexol plasma clearance measurement in older adults with chronic kidney disease-sampling time matters, Nephrol Dial Transplant, 2015.

9.      van der Giet, M.: [Diabetic nephropathy: Antihypertensives don't reduce mortality] (Article in German), Dtsch Med Wochenschr., 2015.

10.    Reshetnik, A. Scheurig-Muenkler, C.; van der Giet, M.;  Tölle, M.: High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease, Clin Case Rep. 2015.

1.      Martus, P., Ebert, N.; van der Giet, M.; Jakob, O.; Schaeffner, E. S.: An efficient approach for glomerular filtration rate assessment in older adults. Br. J. Clin. Pharmacolol., 2014.

2.      Schulz, A.;  Boeringer, F.; Swifka, J.; Kretschmer, A.; Schaefer, M.; Jankowski, V.; van der Giet, M.; Schuchardt, M., Toelle, M.; Tepel, M.; Schlieper, G.; Zidek, W.; Jankowski, J.: A highly sensitive method for quantification of iohexol, Anal. Methods, 2014.

3.      Prüfer, J.; Schuchardt, M.; Tölle, M.; Prüfer, N.; Höhne, M.; Zidek, W.; van der Giet, M.: Harmful effects of the azathioprine metabolite 6-mercaptopurine in vascular cells: induction of mineralization, PLos One, 2014.

4.      Compton, F.; Vogel, M.; Zidek, W.; van der Giet, M.; Westhoff, T.: Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis in Critically Ill Patients, Ther Apher Dial., 2014.

5.      Compton, F.; Bojarski, C.; Siegmund, B.; van der Giet, M.: Use of a nutrition support protocol to increase enteral nutrition delivery in critically ill patients, Am J Crit Care, 2014.

6.      van der Giet, M.: How to unravel hyperaldosteronism in clinical practice, MMW Fortschr Med., 2014.

7.      Tschulakow, A.; Christner, S.; Julien ,S.; Ludinsky, M.; van der Giet, M.; Schraermeyer, U.: Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys, PLoS One, 2014.

1.     Schaeffner, E.S., et al., Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med, 2012, 157(7):471-81.

2.     Schuchardt, M.; Tölle, M.; van der Giet, M.: P2Y purinoceptors as potential emerging therapeutical target in vascular disease. Curr Pharm Des., 2012.

3.    Weiss, W.; Gohlisch, C.; Harsch-Gladisch, C.; Tölle, M.; Zidek, W.; van der Giet, M.: Oscillometric estimation of central blood pressure: validation of the Mobil-O-Graph in comparison with the SphygmoCor device. Blood Press Monit., 2012, 17(3):128-31. 

4.    Seibert, F.S.; van der Giet, M.; Zidek, W.; Westhoff, T.H.: Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome revisited. Clin Nephrol., 2012 77(4): p. 345-6.

5.    Danquah, I.; Bedu-Addo, G.; Terpe, K.J.; Micah, F.; Amoako, Y. A.; Awuku, Y.A.; Dietz, E.; van der Giet, M.; Spranger, J.; Mockenhaupt, F.P.: Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health, 2012. 12: p. 210.

6.    Tölle, M.; Huang, T.; Schuchardt, M.; Jankowski, V.; Prüfer, N.; Jankowski, J.; Tietge, U.J.; Zidek, W.; van der Giet, M.: High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. 2012. Cardiovasc Res. 94(1):154-62.

7.    Weichhart, T.; Kopecky, C.; Kubicek, M.; Haidinger, M.; Döller, D.; Katholnig, K., Suarna, C.; Eller, P.; Tölle, M.; Gerner, C.; Zlabinger, G.J.; van der Giet, M.; Hörl, W.H.; Stocker, R.; Säemann, M.D.: Serum amyloid A in uremic HDL promotes inflammation. 2012. J Am Soc Nephrol. 23(5):934-47.

8.    Wiedon, A.; Tölle, M.; Bastine, J.; Schuchardt, M.; Huang, T.; Jankowski, V.; Jankowski, J.; Zidek, W.; van der Giet, M.: Uridine adenosine tetraphosphate (Up4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y2 receptor and cross-communication to the PDGF receptor. Biochem Biophys Res Commun. 2012. 417(3):1035-40.

9.    de Boer, J.F.; Annema, W.; Schreurs, M.; van der Veen, J.N.; van der Giet, M.; Nijstad, N.; Kuipers, F.; Tietge, U.J.: Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice. J Lipid Res. 2012. 53(3):348-57.

10.    Schuchardt, M.; Tölle, M.; Prüfer, J.; Prüfer, N.; Huang, T.; Jankowski, V.; Jankowski, J.; Zidek, W.; van der Giet, M.: Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification. Kidney Int. 2012. 81(3):256-65.

11.     van der Giet, M., [Dual blockade of the renin-angiotensin system in hypertensive treatment: no]. Dtsch Med Wochenschr, 2012. 137(48): p. 2499.

12.    Pagonas, N.; Hörstrup, J.; Schmidt, D.; Benz, P.; Schindler, R.; Reinke, P.; van der Giet, M.; Zidek, W; Westhoff, T.H.: Prophylaxis of recurrent urinary tract infection after renal transplantation by cranberry juice and L-methionine. 2012. Transplant Proc. 2012. 44(10):3017-21.

1. Zeier, M.; Van Der Giet, M.: Calcineurin inhibitor sparing regimens using m-target of rapamycin inhibitors: an opportunity to improve cardiovascular risk following kidney transplantation? Transpl Int, 2011. 24(1): p. 30-42.

2.     Seibert, F.; Behrendt, C.; Schmidt, S.; van der Giet, M.; Zidek, W.; Westhoff, T.H.: Differential effects of cyclosporine and tacrolimus on arterial function. Transpl Int. 2011. 24(7):708-15.

3.     Schuchardt, M.; Tölle, M.; Prüfer, J.; van der Giet, M.: Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. Br J Pharmacol. 2011. 163(6):1140-62.

4.    http://www.ncbi.nlm.nih.gov/pubmed/20972769 Van Linthout, S.; Spillmann, F.; Graiani, G.; Miteva, K.; Peng, J.; Van Craeyveld, E.; Meloni, M.; Tölle, M.; Escher, F.; Subasigüller, A.; Doehner, W.; Quaini, F.; De Geest, B.; Schultheiss, H.P.; Tschöpe, C.: Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation. J Mol Med (Berl). 2011. 89(2):151-60.

5.    Jankowski, V.; Tölle, M.; Santos, R.A.; Günthner, T.; Krause, E.; Beyermann, M.; Welker, P.; Bader, M.; Pinheiro, S.V.; Sampaio, W.O.; Lautner, R.; Kretschmer, A.; van der Giet, M.; Zidek, W.; Jankowski, J.: Angioprotectin: an angiotensin II-like peptide causing vasodilatory effects. FASEB J. 2011. 25(9):2987-95.

6.    Schuchardt, M.; Prüfer, J.; Prüfer, N.; Wiedon, A.; Huang, T.; Chebli, M.; Jankowski, V.; Jankowski, J.; Schäfer-Korting, M.; Zidek, W.; van der Giet, M.; Tölle, M.: The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J Mol Med (Berl). 2011. 89(8):799-810.

1. Annema, W.; Nijstad, N.; Tölle, M.; de Boer, J.F.; Buijs, R.V.; Heeringa, P.; van der Giet, M.; Tietge, U.J.: Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2). J Lipid Res. 2010. 51(4):743-54.

2. Arndt, R.; Schmidt, S.; Loddenkemper, C.; Grünbaum, M.; Zidek, W.; van der Giet, M., Westhoff, T.H.: Noninvasive evaluation of renal allograft fibrosis by transient elastography--a pilot study. Transpl Int. 2010. 23(9):871-7.

3. Bode, C.; Sensken, S.C.; Peest, U.; Beutel, G.; Thol, F.; Levkau, B.; Li, Z.; Bittman, R.; Huang, T.; Tölle, M.; van der Giet, M.; Gräler, M.H.: Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. J Cell Biochem. 2010. 109(6):1232-43.

4. Hoffmann, C.; Compton, F.; Schäfer, J.H.; Steiner, U.; Fuller, T.F.; Schostak, M.; Zidek, W.; van der Giet, M.; Westhoff, T.H.: Intraoperative assessment of kidney allograft perfusion by laser-assisted indocyanine green fluorescence videography. Transplant Proc. 2010. 42(5):1526-30.

5. Potteck, H.; Nieuwenhuis, B.; Lüth, A.; van der Giet, M.; Kleuser, B.: Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation. 2010. 26(1):67-78.

6. Schaeffner, E.S., van der Giet, M.; Gaedeke, J.; Tölle, M.; Ebert, N.; Kuhlmann, M.K.; Martus, P.: The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach. Eur J Epidemiol., 2010. 25(3):203-10.

7. Tolle, M., Schuchardt, M.; van der Giet, M.: Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins. Curr Pharm Des, 2010. 16(13): p. 1468-79.

8. Tölle, M.; Schuchardt, M.; Wiedon, A.; Huang, T.; Klöckel, L.; Jankowski, J.; Jankowski, V.; Zidek, W.; van der Giet, M.: Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol. 2010. 161(3):530-40.

9. van der Giet, M.; Tölle, M.; Pratico, D.; Lufft, V.; Schuchardt, M.; Hörl, M.P.; Zidek, W.; Tietge, U.J.: Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease. J Mol Med (Berl)., 2010. 88(1):75-83.

10. Wassertheurer, S.; Kropf, J.; Weber, T.; van der Giet, M.; Baulmann, J.; Ammer, M.; Hametner, B.; Mayer, C.C.; Eber, B.; Magometschnigg, D.: A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens., 2010. 24(8):498-504.

11. Wei, W.; Tölle, M.; Zidek, W.; van der Giet, M.: Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit., 2010. Aug;15(4):225-8.

1.  Günthner, T.; Jankowski, V.; Kretschmer, A.; Nierhaus, M.; van der Giet, M.; Zidek, W.; Jankowski, J.: Endothelium and vascular smooth muscle cells in the context of uremia. Semin Dial., 2009. 22(4):428-32.

2. Jankowski, V.; van der Giet, M.; Mischak, H.; Morgan, M.; Zidek, W.; Jankowski, J.: Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system. Br J Pharmacol., 2009. 157(7):1142-53.

3. Nijstad, N.; Wiersma, H.; Gautier, T.; van der Giet, M., Maugeais, C.; Tietge, U.J.: Scavenger receptor BI-mediated selective uptake is required for the remodeling of high density lipoprotein by endothelial lipase. J Biol Chem. 2009. 284(10):6093-100.

4.  Schmidt, S.; Foert, E.; Zidek, W.; van der Giet, M.; Westhoff, T.H.: Emphysematous pyelonephritis in a kidney allograft. Am J Kidney Dis. 2009. 53(5):895-7.

5. Westermann, D.; Riad, A.; Richter, U.; Jäger, S.; Savvatis, K.; Schuchardt, M.; Bergmann, N.; Tölle, M.; Nagorsen, D.; Gotthardt, M.; Schultheiss, H.P.; Tschöpe, C.: Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Basic Res Cardiol. 2009. 104(5):499-509.

6. Westhoff, T.H.; Schmidt, S.; Meissner, R.; Zidek, W.; van der Giet, M.: The impact of pulse pressure on the accuracy of wrist blood pressure measurement. J Hum Hypertens. 2009. 23(6):391-5.

7.  Westhoff, T.H.; Vergoulidou, M.; Loddenkemper, C.; Schwartz, S.; Hofmann, J.; Schneider, T.; Zidek, W.; van der Giet, M.: Chronic norovirus infection in renal transplant recipients. Nephrol Dial Transplant. 2009. 24(3):1051-3.

1. Nissel, R.; Faraj, S.; Sommer, K.; Henning, L.; van der Giet, M.; Querfeld, U.: Oxidative stress markers in young hemodialysis patients - a pilot study. Clin Nephrol., 2008. 70(2):135-43.

2. Schmidt, S.; Westhoff, T.H.; Krauser, P.; Zidek, W.; van der Giet, M.: The uraemic toxin phenylacetic acid increases the formation of reactive oxygen species in vascular smooth muscle cells. Nephrol Dial Transplant., 2008. 23(1):65-71.

3. Schmidt S, Westhoff TH, Krauser P, Ignatius R, Jankowski J, Jankowski V, Zidek W, van der Giet M.: The uraemic toxin phenylacetic acid impairs macrophage function. Nephrol Dial Transplant., 2008. 23 (11): p. 3485-93.

4.  Tölle M.; Jankowski, V.; Schuchardt, M.; Wiedon, A.; Huang, T.; Hub, F.; Kowalska, J.; Jemielity, J.; Guranowski, A.; Loddenkemper, C.; Zidek, W.; Jankowski, J.; van der Giet, M.: Adenosine 5'-tetraphosphate is a highly potent purinergic endothelium-derived vasoconstrictor. Circ Res., 2008. 103(10):1100-8.

5.  Tölle, M.; Pawlak, A.; Schuchardt, M.; Kawamura, A.; Tietge, U.J.; Lorkowski, S.; Keul, P.; Assmann, G.; Chun, J.; Levkau, B.; van der Giet, M.; Nofer, J.R.: HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler Thromb Vasc Biol., 2008. 28(8):1542-8.

6. Tölle, M.; van der Giet, M.: Cardiorenovascular effects of urotensin II and the relevance of the UT receptor. Peptides, 2008. 29(5): p. 743-63.

7. van der Giet, M.; Tölle, M.; Kleuser, B.: Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease. Biol Chem., 2008. 389(11): p. 1381-90.

8. Westhoff, T.H.; Schmidt, S.; Gross, V.; Joppke, M.; Zidek, W.; van der Giet, M.; Dimeo, F.: The cardiovascular effects of upper-limb aerobic exercise in hypertensive patients. J Hypertens. 2008. 26(7):1336-42.

9. Westhoff, T.H.; Schmidt, S.; Zidek, W.; van der Giet, M.: Validation of the Stabil-O-Graph blood pressure self-measurement device. J Hum Hypertens., 2008. 22(3):233-5.

1.       Jankowski, V.; Karadogan, S.; Vanholder, R.; Nofer, J.R.; Herget-Rosenthal, S.; van der Giet, M.; Tölle, M.; Tran, T.N.; Zidek, W.; Jankowski, J.: Paracrine stimulation of vascular smooth muscle proliferation by diadenosine polyphosphates released from proximal tubule epithelial cells. Kidney Int, 2007. 71(10): p. 994-1000.

2.      Jankowski, V.; Meyer, A.A.; Schlattmann, P.; Gui, Y.; Zheng, X.L.; Stamcou, I.; Radtke, K.; Tran, T.N.; van der Giet, M.; Tölle, M.; Zidek, W., Jankowski, J.: Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives. Arterioscler Thromb Vasc Biol, 2007. 27(8): p. 1776-81.

3. Jankowski, V.; Vanholder, R.; van der Giet, M.; Tölle, M.; Karadogan, S.; Gobom, J., Furkert, J.; Oksche, A.; Krause, E.; Tran, T.N.; Tepel, M., Schuchardt, M., Schlüter, H.; Wiedon, A.; Beyermann, M.; Bader, M.; Todiras, M.; Zidek, W.; Jankowski, J.: Mass-spectrometric identification of a novel angiotensin peptide in human plasma. Arterioscler Thromb Vasc Biol, 2007. 27(2): p. 297-302.

4.      Keller, C.D.; Rivera Gil, P.; Tölle, M.; van der Giet, M.; Chun, J.; Radeke, H.H.; Schäfer-Korting, M.; Kleuser, B.: Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling. Am J Pathol, 2007. 170(1): p. 281-92.

5.      Keul, P.; Tölle, M.; Lucke, S.; von Wnuck Lipinski, K.; Heusch, G.; Schuchardt, M.; van der Giet, M.; Levkau, B.: The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 2007. 27(3): p. 607-13.

6.      Schmidt, S.; Westhoff, T.H.; Compton, F.; Zidek, W.; van der Giet, M.:Avoiding the cross-talk phenomenon when assessing cardiac output using the transpulmonary thermodilution technique via the femoral vein access. Crit Care Med, 2007. 35(11): p. 2670.

7.       Schmidt, S.; Westhoff, T.H.; Hofmann, C.; Schaefer, J.H.; Zidek, W.; Compton, F.; van der Giet, M.:Effect of the venous catheter site on transpulmonary thermodilution measurement variables. Crit Care Med, 2007. 35(3): p. 783-6.

8.       Tölle, M.; Levkau, B.; Kleuser, B.; van der Giet, M.: Sphingosine-1-phosphate and FTY720 as anti-atherosclerotic lipid compounds. Eur J Clin Invest, 2007. 37(3): p. 171-9.

9.       Westhoff, T.H.; Franke, N.; Schmidt, S.; Vallbracht-Israng, K.; Meissner, R.; Yildirim, H.; Schlattmann, P.; Zidek, W.; Dimeo, F.; van der Giet, M.: Too old to benefit from sports? The cardiovascular effects of exercise training in elderly subjects treated for isolated systolic hypertension. Kidney Blood Press Res, 2007. 30(4): p. 240-7.

10.      Westhoff, T.H.; Franke, N.; Schmidt, S.; Vallbracht-Israng, K.; Zidek, W.; Dimeo, F.; van der Giet, M.: Beta-blockers do not impair the cardiovascular benefits of endurance training in hypertensives. J Hum Hypertens, 2007. 21(6): p. 486-93.

11.      Westhoff, T.H.; Schmidt, S.; Glander, P.; Liefeld, L.; Martini, S.; Offermann, G.; Neumayer, H.H.; Zidek, W.; van der Giet, M.; Budde, K.: The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients. Nephrol Dial Transplant, 2007. 22(8): p. 2354-8.

12.      Westhoff, T.H.; Schmidt, S.; Vallbracht-Israng, K.; Yildirim, H.; Franke, N.; Dimeo, F.; Zidek, W.; van der Giet, M.:Small artery elasticity assessed by pulse wave analysis is no measure of endothelial dysfunction. J Hypertens, 2007. 25(3): p. 571-6.

13.      Westhoff, T.H. and M. van der Giet: Tacrolimus in the treatment of idiopathic nephrotic syndrome. Expert Opin Investig Drugs, 2007. 16(7): p. 1099-110.

1.      Becker, S.; Schomburg, L.; Renko, K.; Tölle, M.; van der Giet, M.; Tietge, U.J.: Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans. Biochem Biophys Res Commun, 2006. 339(3): p. 833-9.

2.      Tölle, M.; Giebing, G.; Tietge, U.J.; Jankowski, J.; Jankowski, V.; Henning, L.; Hörl, M.P.; Weiss, W.; Zidek, W.; van der Giet, M.: Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation. J Hypertens, 2006. 24(10): p. 1991-2000.

3.      van der Giet, M. and W. Zidek, [Haemodialysis and hypertension]. Dtsch Med Wochenschr, 2006. 131(46): p. 2605-9.

4.      Westhoff, T.H.; Loddenkemper, C.; Hörl, M.P.; Schmidt, S.; Anagnostopoulos, I.; Hummel, M.; Zidek, W.; van der Giet, M.: Dermatopathic lymphadenopathy: a differential diagnosis of enlarged lymph nodes in uremic pruritus. Clin Nephrol, 2006. 66(6): p. 472-5.

5.      Westhoff, T.H.; Schmidt, S.; Zidek, W.; Beige, J.; van der Giet, M.: Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome. Clin Nephrol, 2006. 65(6): p. 393-400.

6.      Westhoff, T.H.; Straub-Hohenbleicher, H.; Basdorf, M.; van der Giet, S.; Schmidt, S.; Offermann, G.; Schlattmann, P.; Zidek, W.; van der Giet, M.: Time-dependent effects of cadaveric renal transplantation on arterial compliance in patients with end-stage renal disease. Transplantation, 2006. 81(10): p. 1410-4.

7.      Westhoff, T.H.; Waldherr, R.; Loddenkemper, C.; Ries, W.; Zidek, W.; van der Giet, M.: Mesangial IgA deposition in minimal change nephrotic syndrome: coincidence of different entities or variant of minimal change disease? Clin Nephrol, 2006. 65(3): p. 203-7.

8.      Westhoff, T.H.; Zidek, W., Uharek, L.; Steinhoff-Georgieva, J.; van der Giet, M.: Impairment of renal function in Schnitzler's syndrome. J Nephrol, 2006. 19(5): p. 660-3.

1.      Giebing, G.; Tölle, M.; Jürgensen, J.; Eichhorst, J.; Furkert, J.; Beyermann, M.; Neuschäfer-Rube, F.; Rosenthal, W.; Zidek, W.; van der Giet, M.; Oksche, A.: Arrestin-independent internalization and recycling of the urotensin receptor contribute to long-lasting urotensin II-mediated vasoconstriction. Circ Res, 2005. 97(7): p. 707-15.

2.      Jankowski, V.; Tölle, M.; Vanholder, R.; Schönfelder, G.; van der Giet, M.; Henning, L.; Schlüter, H.; Paul, M.; Zidek, W.; Jankowski, J.: Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor. Nat Med, 2005. 11(2): p. 223-7.

3.      Jankowski, V.; Vanholder, R.; van der Giet, M.; Henning, L.; Tölle, M.; Schönfelder, G.; Krakow, A.; Karadogan, S.; Gustavsson, N.; Gobom, J.; Webb,  J.; Lehrach, H.; Giebing, G.; Schlüter, H.; Hilgers, K.F.; Zidek, W.; Jankowski, J.: Detection of angiotensin II in supernatants of stimulated mononuclear leukocytes by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass analysis. Hypertension, 2005. 46(3): p. 591-7.

4.      Tölle, M.; Levkau, B.; Keul, P.; Brinkmann, V.; Giebing, G.; Schönfelder, G.; Schäfers, M.; von Wnuck Lipinski, K.; Jankowski, J.; Jankowski, V.; Chun, J.; Zidek, W.; Van der Giet, M.: Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res, 2005. 96(8): p. 913-20.

5.      van der Giet, M., [Isolated systolic hypertension]. Dtsch Med Wochenschr, 2005. 130(46): p. 2653-6.

6.      van der Giet, M. and M. Paul, [New tendencies in combination antihypertensive therapy]. MMW Fortschr Med, 2005. 147(46): p. 44-6.

7.      Westhoff, T.H.; Scheid, S.; Tölle, M.; Kaynak, B.; Schmidt, S.; Zidek, W.; Sperling, S.; van der Giet, M.: A physiogenomic approach to study the regulation of blood pressure. Physiol Genomics, 2005. 23(1): p. 46-53.

8.      Westhoff, T.H.; Straub-Hohenbleicher, H.; Schmidt, S.; Tölle, M.; Zidek, W.; van der Giet, M.: Convenience of ambulatory blood pressure monitoring: comparison of different devices. Blood Press Monit, 2005. 10(5): p. 239-42.

9.      Zhu, Z.; Zhu, S.; Liu, D.; Yu, Z.; Yang, Y.; van der Giet, M.; Tepel, M.: GATA4-mediated cardiac hypertrophy induced by d-myo-inositol 1,4,5-tris-phosphate. Biochem Biophys Res Commun, 2005. 338(2): p. 1236-40.

1.      Levkau, B.; Hermann, S.; Theilmeier, G.; van der Giet, M.; Chun, J.; Schober, O.; Schäfers, M.: High-density lipoprotein stimulates myocardial perfusion in vivo. Circulation, 2004. 110(21): p. 3355-9.

2.      Nofer, J.R.; van der Giet, M.; Tölle, M.; Wolinska, I.; von Wnuck Lipinski, K.; Baba, H.A.; Tietge, U.J.; Gödecke, A.; Ishii, I.; Kleuser, B.; Schäfers, M.; Fobker, M.; Zidek, W.; Assmann, G.; Chun, J.; Levkau, B.: HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest, 2004. 113(4): p. 569-81.

3.      van der Giet, M. and Tolle, M.: Why HDL cholesterol is 'good cholesterol'. Eur J Clin Invest, 2004. 34(4): p. 247-8.

4.      Zhu, Z.; Zhu, S.; Zhu, J.; van der Giet, M.; Tepel, M.: Effect of sodium on vasoconstriction and angiotensin II type 1 receptor mRNA expression in cold-induced hypertensive rats. Clin Exp Hypertens, 2004. 26(6): p. 475-83.

5.      Zidek, W., Tepel, M. and van der Giet, M.: [Medical treatment of hypertension--what treatment for what patients?]. MMW Fortschr Med, 2004. 146(22): p. 31-4.

1.     Jankowski, J.; Jankowski, V.; Laufer, U.; van der Giet, M.; Henning, L.; Tepel, M.; Zidek, W.; Schlüter, H.: Identification and quantification of diadenosine polyphosphate concentrations in human plasma. Arterioscler Thromb Vasc Biol, 2003. 23(7): p. 1231-8.

2.     Jankowski, J.; Schlüter, H.; Henning, L.; van der Giet, M.; Jankowski, V.; Zidek, W.; Tepel M.: The AN69 hemofiltration membrane has a decreasing effect on the intracellular diadenosine pentaphosphate concentration of platelets. Kidney Blood Press Res, 2003. 26(1): p. 50-4.

3.     Jankowski, J.; van der Giet, M.; Jankowski, V.; Schmidt, S.; Hemeier, M.; Mahn, B.; Giebing, G.; Tolle, M.; Luftmann, H.; Schluter, H.; Zidek, W.; Tepel, M.: Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest, 2003. 112(2): p. 256-64.

4.     Tepel, M.; van der Giet, M.; Statz, M.; Jankowski, J.; Zidek, W.: The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.Circulation, 2003. 107(7): p. 992-5.

5.     van der Giet, M.; Zidek, W.: [Isolated systolic hypertension. Need for new assessment]. MMW Fortschr Med, 2003. 145(7): p. 53-4.

6.     Westhoff, T.; Jankowski, J.; Schmidt, S.; Luo, J.; Giebing, G.; Schlüter, H.; Tepel, M.; Zidek, W.; van der Giet, M.: Identification and characterization of adenosine 5'-tetraphosphate in human myocardial tissue. J Biol Chem, 2003. 278(20): p. 17735-40.

1.     Tepel, M.; van der Giet, M.; Park, A.; Zidek, W.: Association of calcium channel blockers and mortality in haemodialysis patients. Clin Sci (Lond), 2002. 103(5): p. 511-5.

2.     Tepel, M.; van der Giet, M.; Zidek, W.:[Antioxidant therapy in vascular and renal diseases]. Med Klin (Munich), 2002. 97(3): p. 144-51.

3.     van der Giet, M.; Erinola, M.; Zidek, W.; Tepel, M.: Captopril and quinapril reduce reactive oxygen species. Eur J Clin Invest, 2002. 32(10): p. 732-7.

4.     van der Giet, M.; Giebing, G.; Tolle, M.; Schmidt, S.: The Role of P2Y Receptors in the Control of Blood Pressure. Drug News Perspect, 2002. 15(10): p. 640-646.

5.     van der Giet, M.; Schmidt, S.; Tölle, M.; Jankowski, J.; Schlüter, H.; Zidek, W.; Tepel, M.: Effects of dinucleoside polyphosphates on regulation of coronary vascular tone. Eur J Pharmacol, 2002. 448(2-3): p. 207-13.

6.     Zhu, Z.; Zhu, S.; Zhu, J.; van der Giet, M.; Tepel, M.: Endothelial dysfunction in cold-induced hypertensive rats. Am J Hypertens, 2002. 15(2 Pt 1): p. 176-80.

1.     Cinkilic, O.; King, B. F.; van der Giet, M.; Schlüter, H.; Zidek, W.; Burnstock, G.: Selective agonism of group I P2X receptors by dinucleotides dependent on a single adenine moiety. J Pharmacol Exp Ther, 2001. 299(1): p. 131-6.

2.     Jankowski, J.; Hagemann, J.; Yoon, M.S.; van der Giet, M.; Stephan, N.; Zidek, W.; Schlüter, H.; Tepel, M.: Increased vascular growth in hemodialysis patients induced by platelet-derived diadenosine polyphosphates. Kidney Int, 2001. 59(3): p. 1134-41.

3.     Jankowski, J.; Tepel, M.; Stephan, N.; van der Giet, M.; Breden, V.; Zidek, W.; Schlüter, H.: Characterization of p-hydroxy-hippuric acid as an inhibitor of Ca2+-ATPase in end-stage renal failure. Kidney Int Suppl, 2001. 78: p. S84-8.

4.     Tepel, M., van der Giet, M.; Zidek, W.: Efficacy and tolerability of angiotensin II type 1 receptor antagonists in dialysis patients using AN69 dialysis membranes. Kidney Blood Press Res, 2001. 24(1): p. 71-4.

5.     van der Giet, M.; Schmid, A.; Jankowski, J.; Schlüter, H.; Zidek, W.; Tepel, M.: CoenzymeA glutathione disulfide is a potent modulator of angiotensin II-induced vasoconstriction. Am J Hypertens, 2001. 14(2): p. 164-8.

6.     van der Giet, M.; Westhoff, T.; Cinkilic, O.; Jankowski, J.; Schlüter, H.; Zidek, W.; Tepel, M.: The critical role of adenosine and guanosine in the affinity of dinucleoside polyphosphates to P(2X)-receptors in the isolated perfused rat kidney. Br J Pharmacol, 2001. 132(2): p. 467-74.

1.     Jankowski, J.; Schröter, A.; Tepel, M.; van der Giet, M.; Stephan, N.; Luo, J.; Zidek, W.; Schlüter, H.: Isolation and characterization of coenzyme A glutathione disulfide as a parathyroid-derived vasoconstrictive factor. Circulation, 2000. 102(20): p. 2548-52.

2.     Tepel, M.; Sanner, B.M.; van der Giet, M.; Zidek, W.: Increased sodium-proton antiporter activity in patients with obstructive sleep apnoea. J Sleep Res, 2000. 9(3): p. 285-91.

3.     Tepel, M.; van der Giet, M.; Schwarzfeld, C.; Laufer, U.; Liermann, D.; Zidek, W.: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med, 2000. 343(3): p. 180-4.

4.     Tepel, M.; van der Giet, M.; Zidek, W.: [Progressive renal failure. Why blood pressure must now be monitored]. MMW Fortschr Med, 2000. 142(25): p. 42-4.

1.      Jankowski, J.; Potthoff, W.; van der Giet, M.; Tepel, M.; Zidek, W.; Schlüter, H.: High-performance liquid chromatographic assay of the diadenosine polyphosphates in human platelets. Anal Biochem, 1999. 269(1): p. 72-8.

2.     Jankowski, J.; Tepel, M.; van der Giet, M.; Tente, I.M.; Henning, L.; Junker, R.; Zidek, W.; Schlüter, H.: Identification and characterization of P(1), P(7)-Di(adenosine-5')-heptaphosphate from human platelets. J Biol Chem, 1999. 274(34): p. 23926-31.

3.     Luo, J.; Jankowski, J.; Knobloch, M.; van der Giet, M.; Gardanis, K.; Russ, T.; Vahlensieck, U.; Neumann,  J.; Schmitz, W; Tepel, M.; Deng, M.C.; Zidek, W.; Schlüter, H.: Identification and characterization of diadenosine 5',5"'-P1,P2 -diphosphate and diadenosine 5',5"'-P1,P3-triphosphate in human myocardial tissue. FASEB J, 1999. 13(6): p. 695-705.

4.     Tepel, M.; Pytlik, M.; van der Giet, M.; Schlüter, H.; Jankowski, J.; Zidek, W.: Effect of dexamethasone on the lymphocytic Na+/H+ antiporter activity. J Hypertens, 1999. 17(11): p. 1553-6.

5.     Tepel, M.; van der Giet, M.; Brukamp, K.; Weyer, J.; Zidek, W.: Regulation of the Na+/H+ antiporter in patients with mild chronic renal failure: effect of glucose. Kidney Int, 1999. 56(1): p. 172-80.

6.     Tepel, M.; van der Giet, M.; Zidek, W.: Therapy of hypertensive emergencies. Saudi J Kidney Dis Transpl, 1999. 10(3): p. 279-82.

7.      van der Giet, M.; Cinkilic, O.; Jankowski, J.; Tepel, M.; Zidek, W.; Schlüter, H.: Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney. Br J Pharmacol, 1999. 127(6): p. 1463-9.

1. Schlüter, H.; Grobeta.; Bachmann, J.; Kaufmann, R.; van der Giet, M.; Tepel, M.; Nofer, J.R.; Assmann, G.; Karas, M.; Jankowski, J.; Zidek, W.: Adenosine(5') oligophospho-(5') guanosines and guanosine(5') oligophospho-(5') guanosines in human platelets. J Clin Invest, 1998. 101(3): p. 682-8.

2. Tepel, M.; Jankowski, J.; Ruess, C.; Steinmetz, M.; van der Giet, M.; Zidek, W.: Activation of Na+, H+ exchanger produces vasoconstriction of renal resistance vessels. Am J Hypertens, 1998. 11(10): p. 1214-21.

3. van der Giet, M.; Jankowski, J.; Schlüter, H.; Zidek, W.; Tepel, M.: Mediation of the vasoactive properties of diadenosine tetraphosphate via various purinoceptors. J Hypertens, 1998. 16(12 Pt 2): p. 1939-43.

1. Raff, T.; van der Giet, M.; Endemann, D.; Wiederholt, T.; Paul, M.: Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques, 1997. 23(3): p. 456-60.

2. Tepel, M.; Jankowski, J.; Schlüter, H.; Bachmann, J.; van der Giet, M.; Ruess, C.; Terliesner, J.; Zidek, W.:Diadenosine polyphosphates' action on calcium and vessel contraction. Am J Hypertens, 1997. 10(12 Pt 1): p. 1404-10.

3. van der Giet, M.; Khattab, M.; Börgel, J.; Schlüter, H.; Zidek, W.: Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol, 1997. 120(8): p. 1453-60.

Schlüter, H.; Meissner, M.; van der Giet, M.; Tepel, M.; Bachmann, J.; Gross, I.; Nordhoff, E.; Karas, M.; Spieker, C.; Witzel, H. et al.: Coenzyme A glutathione disulfide. A potent vasoconstrictor derived from the adrenal gland. Circ Res, 1995. 76(4): p. 675-80.

Schlüter, H.; Offers, E.; Brüggemann, G.; van der Giet, M.; Tepel, M.; Nordhoff, E.; Karas, M.; Spieker, C.; Witzel, H.; Zidek, W.: Diadenosine phosphates and the physiological control of blood pressure. Nature, 1994. 367(6459): p. 186-8.

1. Reshetnik A, Compton F, Schölzel A, Tölle M, Zidek W, Giet MV: Noninvasive oscillometric cardiac output determination in the intensive vare unit – comparison with invasive transpulmonary thermodilution. Sci Rep 2017 Aug 30;7(1):9997.

2. Compton F, Ahlborn R, Weidehoff T: Nurse-directed blood glucose management in a medical intensive care unit. Crit Care Nurse 2017. Jun;37(3):30-40.

1. Schmidt S, Westhoff T, Schlattmann P, Zidek W, Compton F: Analysis of transpulmonary thermodilution data confirms influence of renal replacement therapy on thermodilution hemodynamic measurements. Anesth Analg 2016 May;122(5):1474-9. doi: 10.1213/ANE .0000000000001191Compton F, Vogel M, Zidek W, van der Giet M, Westhoff T. Changes in volumetric hemodynamic parameters induced by fluid removal on hemodialysis in critically ill patients. Ther Apher Dial. 2015 Feb;19(1):23-9.

2. Compton F, Bojarski C, Siegmund B, van der Giet M. Increasing enteral nutrition delivery in critically ill patients: Impact of the implementation of a nutrition support protocol involving early endoscopic placement of a nasojejunal feeding tube. Am J Crit Care. 2014 Sep;23(5):396-403.

Wittrock M, Scholze A, Compton F, Schaefer JH, Zidek W, Tepel M. Noninvasive pulse wave analysis for the determination of central artery stiffness. Microvasc Res. 2009 Mar;77(2):109-12

1. Compton F, Wittrock M, Schaefer JH, Zidek W, Tepel M, Scholze A. Noninvasive cardiac output determination using applanation tonometry-derived radial artery pulse contour analysis in critically ill patients. Anesth Analg. 2008 Jan;106(1):171-4, table of contents.

2. Compton FD, Zukunft B, Hoffmann C, Zidek W, Schaefer JH. Performance of a minimally invasive uncalibrated cardiac output monitoring system (Flotrac/Vigileo) in haemodynamically unstable patients. Br J Anaesth. 2008 Apr;100(4):451-6.

3. Compton F, Hoffmann F, Hortig T, Strauss M, Frey J, Zidek W, Schäfer JH. Pressure ulcer predictors in ICU patients: nursing skin assessment versus objective parameters. J Wound Care. 2008 Oct;17(10):417-20, 422-4. Erratum in: J Wound Care. 2008 Nov;17(11):493.

4. Compton F, Strauss M, Hortig T, Frey J, Hoffmann F, Zidek W, Schäfer JH. [Validity of the Waterlow scale for pressure ulcer risk assessment in the intensive care unit: a prospective analysis of 698 patients]. Pflege. 2008 Feb;21(1):37-48 (German).

Compton F, Hoffmann C, Zidek W, Schmidt S, Schaefer JH. Volumetric hemodynamic parameters to guide fluid removal on hemodialysis in the intensive care unit. Hemodial Int. 2007 Apr;11(2):231-7.